EMMO-02 - Transforming Type 1 Diabetes: Strategies for early detection and treatment (Supported by Sanofi)
Tracks
Room 520-BF
| Monday, August 31, 2026 |
| 8:00 AM - 8:45 AM |
Details
Lunch break symposium supported by Sanofi
Programme:
Ms Preetha Krishnamoorthy, McGill University, Canada
Introduction:
TBC
Programme:
Learning objectives:
1. Review the epidemiology, staging, and clinical landscape of autoimmune T1D.
2. Devise strategies and early detection protocols to assess the risk of developing autoimmune T1D and prevent complications such as DKA.
3. Explore current treatment options and potential immunotherapy interventions under investigation to delay the onset and progression of autoimmune T1D.
| 08:00 – 08:05 | Welcome & Introductions A New Era in Type 1 Diabetes |
| Ms Preetha Krishnamoorthy, McGill University, Canada | |
| 08:05 – 08:15 | Identifying type 1 diabetes before symptoms: Screening & early detection strategies |
| Ms Preetha Krishnamoorthy, McGill University, Canada | |
| 08:15 – 08:20 | Slowing disease progression: The future of T1D interventions |
| Mr Aaron Sihota, University of British Columbia, Canada | |
| 08:20 – 08:35 | Pharmacist-led screening experience |
| Mr Mohamad Cheaib, Canada Mr Aaron Sihota, University of British Columbia, Canada | |
| 08:35 – 08:45 | Panel Discussion and Q&A |
| All Faculty |
